Evropska unija - slovenščina - EMA (European Medicines Agency)

nova laboratories ireland limited - spironolakton - edema; heart failure; liver cirrhosis; ascites; nephrotic syndrome; hyperaldosteronism; essential hypertension - antihypertensives and diuretics in combination - in the management of refractory oedema associated with congestive cardiac failure; hepatic cirrhosis with ascites and oedema, malignant ascites, nephrotic syndrome, diagnosis and treatment of primary aldosteronism, essential hypertension. neonates, children and adolescents should only be treated under guidance of a paediatric specialist (see sections 5. 1 in 5.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

riemser pharma gmbh - spironolakton - obložena tableta - spironolakton 25 mg / 1 tableta - spironolakton

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

riemser pharma gmbh - spironolakton - obložena tableta - spironolakton 50 mg / 1 tableta - spironolakton

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

riemser pharma gmbh - spironolakton - kapsula, trda - spironolakton 100 mg / 1 kapsula - spironolakton

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

janssen-cilag international nv - abirateronacetat - filmsko obložena tableta - abirateronacetat 500 mg / 1 tableta - abirateron

Evropska unija - slovenščina - EMA (European Medicines Agency)

biopartners gmbh - recombinant human interferon alfa-2a - hepatitis c, kronični - immunostimulants, - adult patients with histologically proven chronic hepatitis c who are positive for hepatitis c virus (hcv) antibodies or hcv rna and have elevated serum alanine aminotransferase (alt) without liver decompensation. the efficacy of interferon alfa-2a in the treatment of hepatitis c is enhanced when combined with ribavirin. alpheon should be given alone mainly in case of intolerance or contra-indication to ribavirin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

pharmaand gmbh - peginterferon alfa-2a - hepatitis c, chronic; hepatitis b, chronic - immunostimulants, - chronic hepatitis b adult patients pegasys is indicated for the treatment of hepatitis b envelope antigen (hbeag)-positive or hbeag-negative chronic hepatitis b (chb) in adult patients with compensated liver disease and evidence of viral replication, increased alanine aminotransferase (alt) and histologically verified liver inflammation and/or fibrosis (see sections 4. 4 in 5. paediatric patients 3 years of age and older pegasys is indicated for the treatment of hbeag-positive chb in non-cirrhotic children and adolescents 3 years of age and older with evidence of viral replication and persistently elevated serum alt levels. glede na odločitev, da začne zdravljenje v pediatrični bolniki glej točki 4. 2, 4. 4 in 5. chronic hepatitis c adult patients pegasys is indicated in combination with other medicinal products, for the treatment of chronic hepatitis c (chc) in patients with compensated liver disease (see sections 4. 2, 4. 4 in 5. za virus hepatitisa c (hcv) genotip določene dejavnosti, glej točki 4. 2 in 5. paediatric patients 5 years of age and older pegasys in combination with ribavirin is indicated for the treatment of chc in treatment-naïve children and adolescents 5 years of age and older who are positive for serum hcv-rna. ko se odločate za začetek zdravljenja v otroštvu, je pomembno, da preuči zaviranja rasti povzročijo kombinacija terapije. reverzibilnost zaviranja rasti je negotova. odločitev za zdravljenje mora biti vložena na podlagi primera (glej poglavje 4.

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel

Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

kabazitaksel - koncentrat za raztopino za infundiranje - kabazitaksel 10 mg / 1 ml - kabazitaksel